{"id":45836,"date":"2014-04-25T08:00:59","date_gmt":"2014-04-25T12:00:59","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=45836"},"modified":"2014-04-24T23:14:03","modified_gmt":"2014-04-25T03:14:03","slug":"a-big-mistake","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2014\/04\/25\/a-big-mistake\/","title":{"rendered":"a big mistake&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\" class=\"big\"><a target=\"_blank\" href=\"http:\/\/www.bmj.com\/content\/348\/bmj.g2939\">FDA chief defends Zohydro approval as US states rebel<\/a><\/div>\n<div align=\"center\" class=\"small\">by Michael McCarthy<\/div>\n<div align=\"center\" class=\"middle\"><strong><font color=\"#0033ff\">British Medical Journal<\/font><\/strong>. 2014 348:g2939<\/div>\n<p align=\"justify\">Margaret  Hamburg, commissioner of the US Food and Drug Administration, has  defended her agency&rsquo;s decision to approve the potent long acting opioid  Zohydro ER, arguing that the FDA had to balance the risks of opioid  prescription abuse with &ldquo;the very real medical needs of the estimated  100 million Americans living with severe chronic pain or coping with  pain at the end of life, which is also a major public health problem in  this country.&rdquo; In an address to the National Rx Drug  Abuse Summit being held in Atlanta, Georgia, Hamburg said that the  drug&mdash;an extended release formulation of hydrocodone bitartrate&mdash;offered  an effective option to patients who required around-the-clock opioid  treatment and for whom alternative treatments were inadequate. She  also said that because Zohydro did not contain paracetamol  (acetaminophen), it did not pose the threat of liver toxicity seen with  combination hydrocodone products, such as Vicodin, which did contain  paracetamol.<\/p>\n<p align=\"justify\">Hamburg&rsquo;s comments came as several state  governors moved to severely restrict the use of Zohydro in their states,  citing concerns that the drug, which can be easily crushed for sniffing  or injection, would exacerbate prescription opioid abuse in their  states. On Tuesday 22 April Deval Patrick, the  Massachusetts governor, issued orders to require prescribers to complete  a risk assessment and agreements on pain management treatment before  prescribing Zohydro. Rules issued by the Massachusetts Board of  Registration in Medicine say that these agreements must address drug  screening, pill counts, and safe storage and disposal.<\/p>\n<p align=\"justify\">Patrick  said, &ldquo;We are in the midst of a public health emergency around opioid  abuse and we need to do everything in our power to prevent it from  getting worse.&rdquo; His order came after a court lifted an  outright ban on the drug, which Patrick imposed in March. In that ruling  District Court Judge Rya W. Zobel cited the Supremacy Clause of the US  Constitution, which establishes that federal law supersedes state law if  they conflict. Zobel wrote, &ldquo;If Commonwealth [of  Massachusetts] were able to countermand the FDA&rsquo;s determinations and  substitute its own requirements, it would undermine the FDA&rsquo;s ability to  make drugs available to promote and protect the public health. The  Commonwealth&rsquo;s emergency order thus stands in the way of &lsquo;the  accomplishment and execution of&rsquo; an important federal objective&rdquo;&#8230;<\/p>\n<div align=\"justify\">The FDA&rsquo;s decision to approve Zohydro last  October, despite an 11-2 vote by the agency&rsquo;s advisory board against  approval, triggered a storm of protests from state officials and  politicians in Washington. Late last year attorneys  general from 29 states wrote a letter to Hamburg, calling for her to  either revoke the drug&rsquo;s approval or require the manufacturer to quickly  produce a formulation that deterred misuse. And earlier this year Joe  Manchin, a Democrat senator from West Virginia&mdash;a state that has been  hard hit by the opioid abuse epidemic&mdash;introduced a bill that would force  the FDA to withdraw its approval of the drug.<\/div>\n<\/blockquote>\n<div align=\"justify\">Somebody is making a big mistake here. I think it&#8217;s Margaret  Hamburg of the FDA. I live in the lower part of Appalachia, continuous with the culture of West Virginia mentioned above. Opioid abuse has replaced the &quot;white lightning&quot; of old and the &quot;meth&quot; of more recent times. It&#8217;s endemic. We need a potent long acting new narcotic here like we need more poverty or extra tornados &#8211; which is not at all. There&#8217;s no problem with end of life care around here. There&#8217;s no problem with the current pain management either. Our problem is narcotic abuse, plain and simple. I&#8217;ve dropped the hard drugs from my own DEA License. I only rarely needed to prescribe them, but my DEA number has been purloined several times, so I decided to make that part of it unusable. I refer all requests elsewhere. Narcotics are essential for the practice of medicine, sure enough, but building versions like this that are as well designed for abuse as they are for use is just wrong, and this decision should be dogged for the mistake it is. Over-riding her own advisory committee and the wishes of the States just makes no sense at all&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>FDA chief defends Zohydro approval as US states rebel by Michael McCarthy British Medical Journal. 2014 348:g2939 Margaret Hamburg, commissioner of the US Food and Drug Administration, has defended her agency&rsquo;s decision to approve the potent long acting opioid Zohydro ER, arguing that the FDA had to balance the risks of opioid prescription abuse with [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-45836","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/45836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=45836"}],"version-history":[{"count":3,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/45836\/revisions"}],"predecessor-version":[{"id":45839,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/45836\/revisions\/45839"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=45836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=45836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=45836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}